Almirall, a global biopharmaceutical company focused on medical dermatology, has held an event to celebrate its new offices ...

Lucid Group, a leader in healthcare communications and commercialisation, has announced that Rod MacKenzie, former Executive Vice President and Chief Development Officer at Pfizer, has been appointed ...

As medical knowledge now doubles every 73 days, the challenge for cardiology clinicians has shifted from finding information to mastering precision. At the ...

The antibiotics are needed to combat key drug-resistant bacteria causing severe bloodstream and urinary tract infections, ...

First-in-class oral therapy mimics the effects of exercise with broad potential as a novel treatment for muscle-sparing weight loss ...

OPEN Health today announced the appointment of Cara Priest as Chief People Officer, reinforcing the company’s commitment to building a high-performing culture that supports its continued growth and ...

Appointment marks a pivotal step in Lucid’s next phase of growth, strengthening its ability to translate complex science into real-world impact. Lucid’s US Medical Affairs division unveils new ...

OPEN Health today announced the appointment of Tim Perryman as Global Head of Operations, strengthening the company’s operational leadership as it continues to scale its global capabilities and ...

Sandoz has appointed Armin Metzger as President, Biosimilar Development, Manufacturing & Supply. Metzger will also become a member of the Sandoz Executive Committee (SEC), effective 1 April 2026. Most ...

OPEN Health today announced the appointment of Peter Black as EVP, Global Client Partner and Transformation Lead.

BioDuro has appointed Andrew Thomas (top left) and Stevan Djuric (top right) as Scientific Advisors. Thomas was formerly ...

Odyssey Therapeutics, a clinical-stage biopharmaceutical company, has appointed H. Martin Seidel to its Scientific Advisory ...